304 North Cardinal St.
Dorchester Center, MA 02124
Product Name: Osicent
Manufacturer: Incepta Pharmaceutical
Generic Name: Osimertinib
Brand Name: Tagrisso
Volume: 30 Tablets
Contact: WhatsApp & WeChat +8801304498958
Osicent-80mg-Osimartinib is a type of medication that blocks the activity of a mutant protein called epidermal growth factor receptor (EGFR) tyrosine kinase. It is mainly used to treat metastatic non-small cell lung cancer (NSCLC) caused by a specific mutation, known as T790M. This mutation is common and can develop after treatment with other EGFR tyrosine kinase inhibitors, like erlotinib, gefitinib, and afatinib.
Osicent helps to slow down the growth and spread of cancer cells. It is taken orally once a day and is generally well-tolerated. However, some common side effects of Osicent include diarrhea, nausea, rash, and fatigue.
It is important to note that Osicent is a prescription medication and should only be consumed under the supervision of a doctor. Also, this medication is not a cure for cancer, but it can help to extend survival and improve the quality of life for people with NSCLC. (1)
Osicent-80mg-Osimartinib is used to treat metastatic non-small cell lung cancer (NSCLC) in patients with a specific genetic mutation called the T790M mutation, which is detected by an FDA-approved test. This medication is for patients who have already received treatment with EGFR tyrosine kinase inhibitor (TKI) therapy and have experienced progression of their cancer. In simpler terms, Osicent is a drug that treats advanced lung cancer that has spread to other parts of the body and has a specific type of mutation that can develop after receiving other EGFR TKI drugs that block the activity of the EGFR protein. (2)
Osicent-80mg-Osimartinib, also known as Osicent, is a third-generation tyrosine kinase inhibitor (TKI) that targets the epidermal growth factor receptor (EGFR). EGFR is a protein present on the surface of different types of cells, including cancer cells. When EGFR binds to a growth factor, it triggers signals that stimulate cell growth and division. Mutations in the EGFR gene can cause the protein to become overactive, leading to cancer.
Osicent works by blocking the activity of mutant EGFR, which slows down the growth and spread of cancer cells. By binding to the active site of the mutant EGFR, Osicent prevents it from binding to growth factors and sending signals to the cell to grow and divide.
Osicent is designed to target the T790M mutation, which is a common resistance mutation that can develop after treatment with other EGFR TKIs. This mutation makes the EGFR protein more resistant to other EGFR TKIs, but Osicent is able to overcome this resistance. (3)
The recommended dosage of Osicent-80mg is 80mg orally once daily, with or without food. It is important to take Osicent at the same time each day to maintain consistent blood levels of the medication.
If you miss a dose of Osicent, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose of Osicent to make up for a missed dose.
Osicent should be swallowed whole with water. Do not chew, crush, or dissolve the tablets.
The most common side effects of Osicent-80mg are mild and go away on their own. However, some side effects can be more serious and may require medical attention.
Common side effects: